Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Inspire Medical Systems Inc INSP

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has... see more

Recent & Breaking News (NYSE:INSP)

INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (INSP) and Encourages Long-Term Investors to Contact the Firm

Newsfile 2 days ago

Inspire Medical Systems, Inc. to Present at Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire 2 days ago

UPDATED - Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

GlobeNewswire 6 days ago

Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program

GlobeNewswire 10 days ago

Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

GlobeNewswire November 6, 2024

Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook

GlobeNewswire November 4, 2024

Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference

GlobeNewswire October 30, 2024

Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024

GlobeNewswire October 7, 2024

Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term INSP Shareholders to Contact the Firm

Accesswire September 19, 2024

Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences

GlobeNewswire August 21, 2024

Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program

GlobeNewswire August 6, 2024

Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook

GlobeNewswire August 6, 2024

Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System

GlobeNewswire August 2, 2024

Inspire Medical Systems, Inc. Announces Preliminary Results for Second Quarter of 2024 and Updates 2024 Revenue Outlook

GlobeNewswire July 29, 2024

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France

GlobeNewswire July 23, 2024

Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer

GlobeNewswire July 22, 2024

Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union's Medical Device Regulation for Inspire Therapy

GlobeNewswire July 19, 2024

Lifshitz Law PLLC Announces Investigations of UnitedHealth Group Incorporated (NYSE: UNH), Lyft, Inc. (NASDAQ: LYFT), Inspire Medical Systems, Inc. (NYSE: INSP), and Autodesk, Inc. (NASDAQ: ADSK)

Accesswire July 18, 2024

Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

GlobeNewswire July 2, 2024

Lifshitz Law PLLC Announces Investigations of Ventyx Biosciences, Inc. (NASDAQ: VTYX), TaskUs, Inc. (NASDAQ: TASK), Inspire Medical Systems, Inc. (NYSE: INSP), and Xponential Fitness, Inc. (NYSE: XPOF)

Accesswire June 13, 2024